Protective mucosal SARS-CoV-2 antibodies in the majority of the general population in the Netherlands-Reference-Cited by-同舟云学术

Protective mucosal SARS-CoV-2 antibodies in the majority of the general population in the Netherlands

Published:2024-08 Issue:4 Volume:17 Page:554-564
ISSN:1933-0219
Container-title:Mucosal Immunology
language:en
Short-container-title:Mucosal Immunology

Author:

Verheul Marije K.,Kaczorowska Joanna^ORCID,Hofstee Marloes I.,Schepp Rutger M.^ORCID,Smits Gaby P.^ORCID,Wessels Beljaars Dewi,Kuijer Marjan^ORCID,Schuin Wendy,Middelhof Irene^ORCID,Wong Denise,van Hagen Cheyenne C.E.,Vos Eric R.A.,Nicolaie M. Alina^ORCID,de Melker Hester E.,van Binnendijk Robert S.,van der Klis Fiona R.M.,den Hartog Gerco^ORCID

Funder

Netherlands Ministry of Health Welfare and Sport

Publisher

Elsevier BV

Reference38 articles.

1. Efficacy and effectiveness of SARS-CoV-2 vaccines: a systematic review and meta-analysis;Ghazy;Vaccines (Basel),2022

2. Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England;Andrews;Nat. Med.,2022

3. Tracking immune correlates of protection for emerging SARS-CoV-2 variants;Nilles;Lancet Infect. Dis.,2023

4. Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after Mrna or vector-based COVID-19 vaccinations;Jacobsen;Sci. Rep.,2022

5. The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection;Gallo;Mucosal Immunol.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS‐CoV‐2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era: Input for Future Response;Influenza and Other Respiratory Viruses;2024-06

2. COVID-19 mRNA vaccines induce robust levels of IgG but limited amounts of IgA within the oronasopharynx of young children;2024-04-16